Therefore, the results obtained from HL60 and OCI‐AML3 were verified by analysis of monocytes isolated directly from healthy volunteers and myeloblasts isolated directly from patients diagnosed with AML FAB subtype 4. The gene discussed is RUNX2; the disease is acute myeloid leukemia.